Moderna's Stock Plunge: Pfizer's Vaccine Steals the Show
Update: 2025-09-08
Description
Moderna's stock plunges as Pfizer-BioNTech's updated COVID vaccine data steals the spotlight! Despite FDA approval for Moderna's Spikevax and mNEXSPIKE vaccines, investors remain wary after competitor news and CEO's 2028 break-even target. Is this a buying opportunity or a sign to jump ship?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
